Skip Navigation LinksHome > December 2012 - Volume 18 - Issue > Adalimumab Sustains Deep Remission for 3 Years: Data From CH...
Inflammatory Bowel Diseases:
Abstracts from the 2012 Advances in Inflammatory Bowel Diseases Crohn's & Colitis Foundation's National Clinical & Research Conference December 13-15, 2012 Hollywood, Florida: Clinical Poster Presentations

Adalimumab Sustains Deep Remission for 3 Years: Data From CHARM and ADHERE: P‐58

Sandborn, William1; Colombel, Jean‐Frédéric2; Louis, Edouard3; Panaccione, Remo4; Yang, Mei5; Chao, Jingdong5; Thakkar, Roopal5; Robinson, Anne5; Pollack, Paul5; Mulani, Parvez5

Login